EMA has published a draft reflection paper
outlining the current thinking on the use of artificial intelligence
(AI) to support the safe and effective development, regulation and use
of human and veterinary medicines. This paper, which is now open for
public consultation, reflects on principles relevant to the application
of AI and machine learning (ML) at any step of a medicines’ lifecycle,
from drug discovery to the post-authorisation setting. (...)
It’s time to end Britain’s first-past-the-post election lottery
-
The Gorton and Denton by-election confirmed just how capricious our
electoral system has become
1 ora fa
Post
Nessun commento:
Posta un commento